Axsome Therapeutics Inc

Head of Creative and Corporate Branding

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceuticals, HealthcareIndustries

Position Overview

  • Location Type: Remote (Preference for Central or Eastern time zone with required periodic travel to corporate headquarters)
  • Job Type: Full-time
  • Salary: $212,000 - $280,000

PTC Therapeutics is a global commercial biopharmaceutical company dedicated to extending life’s moments for individuals with rare diseases. We foster an inclusive culture where everyone feels valued, respected, and empowered.

The Head of Creative and Corporate Branding will lead an internal design team, responsible for the creative strategy and execution of all corporate branding initiatives. This strategic role requires a deep understanding of the healthcare industry and a proven track record in corporate branding. The Head will collaborate with senior leadership, investor relations, communications, and cross-functional teams to develop creative solutions that communicate scientific data, align with business objectives, and resonate with target audiences. This role also involves ensuring product creative design is cohesive with overall corporate branding and adheres to regulatory requirements and company SOPs.

Requirements

  • Demonstrated ability to translate a creative brief into compelling branding and campaigns.
  • Strong portfolio showcasing successful branding initiatives within the healthcare industry.
  • Confident leader with strong leadership, communication, and interpersonal skills.
  • Ability to think strategically while maintaining attention to detail.
  • Ability to present ideas clearly and persuasively to all levels of the organization.
  • Knowledge of regulatory requirements and compliance in pharmaceutical marketing.
  • Experience in both creative design and copywriting.
  • Bachelor’s degree in graphic design, branding, marketing, communications, or a related field. A master’s degree is a plus.
  • Minimum of 12 years of experience in creative leadership roles, including healthcare and corporate branding.
  • Minimum of 3 years of direct management experience.
  • Ability to lead teams utilizing design software for both print and digital projects.

Responsibilities

  • Develop and execute innovative and unique creative strategies to enhance the company's brand identity.
  • Lead and inspire internal and external teams of copywriters and designers to deliver high-quality creative content across all platforms, adhering to branding guidelines.
  • Establish corporate brand guidelines and ensure adherence across the organization.
  • Oversee the design of corporate materials, campaigns, and digital content that represents PTC's mission and vision.
  • Collaborate with all functions and levels within the organization to ensure cohesive messaging and branding consistency.
  • Interface with c-suite executives to shape creative strategy and create content for scientific and corporate presentations.
  • Oversee the creative process from concept to completion for corporate campaigns, ensuring timely delivery of high-quality projects.
  • Stay updated with industry trends, competitor activities, and emerging technologies to drive continuous improvement and innovation in branding efforts.
  • Build strong relationships with internal and external partners, including agencies and vendors, to enhance creative performance.

Company Information

Travel Requirements

  • 30% Travel to Warren and Bridgewater, NJ Offices.

Skills

Creative Strategy
Branding
Design Leadership
Healthcare Industry Knowledge
Regulatory Compliance
Cross-functional Collaboration
Communication

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI